PROMETHEUS BIOSCIENCES INC's ticker is RXDX and the CUSIP is 74349U108. A total of 222 filers reported holding PROMETHEUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,494,002 | -93.9% | 13,921 | -93.7% | 0.62% | -91.2% |
| Q4 2022 | $24,464,000 | +102.5% | 222,400 | +8.6% | 7.00% | +71.3% |
| Q3 2022 | $12,079,000 | +41.8% | 204,700 | -32.2% | 4.09% | +55.8% |
| Q2 2022 | $8,517,000 | +3008.4% | 301,700 | +1911.3% | 2.62% | +1659.7% |
| Q1 2021 | $274,000 | – | 15,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 72 Investment Holdings, LLC | 1,848,024 | $198,329,936 | 93.93% |
| CHI Advisors LLC | 934,135 | $100,251,367 | 26.61% |
| Cormorant Asset Management, LP | 1,655,000 | $177,615 | 11.70% |
| Boxer Capital, LLC | 1,897,500 | $203,640 | 10.00% |
| RTW INVESTMENTS, LP | 3,272,104 | $351,162,201 | 7.31% |
| Decheng Capital Management III (Cayman), LLC | 150,000 | $16,098,000 | 6.50% |
| Waypoint Capital Advisors, LLC | 154,466 | $16,577,292 | 5.40% |
| Affinity Asset Advisors, LLC | 150,000 | $16,098,000 | 5.31% |
| Perceptive Advisors | 1,272,694 | $136,585,520 | 4.03% |
| Ikarian Capital, LLC | 125,926 | $13,514,378 | 3.07% |